THALLOUS CHLORIDE TI 201 INJECTION DIN 02485915
Status: Cancelled Post Market
Holder: GE HEALTHCARE CANADA INC
Molecule: THALLIUM CHLORIDE(TI 201)
Available to quote
Health Canada record
| Active ingredient(s) | THALLIUM CHLORIDE(TI 201) 37 MBq |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | SCHEDULE C |
| Class | Radiopharmaceutical |
| ATC | V09GX01 THALLIUM 201 TL CHLORIDE |
| Original market date | 27-May-1982 |
| Current status date | 04-Jun-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
GE Healthcare Canada Inc. — licence 101469, currently licensed, last inspection rating C (2023-02-06).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing THALLIUM CHLORIDE(TI 201)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02327945 | THALLIUM | LANTHEUS MI CANADA INC | Solution | THALLIUM CHLORIDE(TI 201) 2 MCI | Cancelled Post Market |
| 02327961 | THALLIUM | LANTHEUS MI CANADA INC | Solution | THALLIUM CHLORIDE(TI 201) 1 MCI | Cancelled Pre Market |
| 02329824 | THALLIUM, THALLOUS CHLORIDE TI201 | BRISTOL-MYERS SQUIBB CANADA | Liquid | THALLIUM CHLORIDE(TI 201) 1 UNIT | Cancelled Pre Market |
| 02328925 | THALLOUS CHLORIDE TI-201 INJECTION | CURIUM CANADA INC | Solution | THALLIUM CHLORIDE(TI 201) 37 MBq | Dormant |